An observational study in Degenerative Arthritis and Inflammation, sponsored by Elmore Oil Company Pty Ltd. Completed at 1 site in Philippines. Open to participants aged 45 Years to 90 Years. Per ClinicalTrials.gov, last updated 2012-09-13.
Sponsored by Elmore Oil Company Pty Ltd · Observational
The treatment of osteoarthritis, a disease that eventually affects the majority of the older population, involves the alleviation of symptoms such as pain and stiffness, and the reduction of inflammation. A double-blind, placebo-controlled, crossover study will be performed to examine the effect of topical application of Elmore Oil, a herbal remedy (containing Eucalyptus oil, Tea tree oil, Olive oil and Vanilla), which has recently been reported to have anti-inflammatory properties, on the symptoms of osteoarthritis.
Sixty patients were randomly selected and approved for the study, 30 patients with even numbers received the blue dotted Elmore oil and 30 patients with odd numbers got the orange dotted Elmore and were advised to apply 3x daily on the affected knees respectively for four weeks. On the fifth week, they stopped application for 7 days as flush out period. Then on the 6th week a cross over was done on the patients - the blue dotted patients, this time received the orange dotted Elmore Oil and vice-versa and did the application three times daily for another 4 weeks. All throughout the usage, they filled out their diaries (noting the degree of pain, feeling of well being (improved sleep, mobility, ability to do their daily activities at home or at work). A pre-application base line laboratory tests were done, after 4 weeks and after 8 weeks.
3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.
This study's enrollment of 60 is below the median of 155 across 1,057 observational studies indexed under Arthritis.
Browse Arthritis studies →This is the only study on the registry with Elmore Oil Company Pty Ltd as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Population from which the cohorts will be selected are from hospital primary care arthritis clinic.
Exclusion Criteria:
Patients applied the above oil 3 times daily for four weeks and on the fifth week stopped the application completely for the flush out period before switching to Orange Dotted Elmore Oil
Other: Two oily solutions (Blue Dotted and Orange Dotted Elmore Oils)
Patients give this oil applied it three times daily on the affected knees for four weeks and on the fifth week, stopped the application totally for the flush out period before switching to the Blue Dotted Elmore Oil.
Other: Two oily solutions (Blue Dotted and Orange Dotted Elmore Oils)
Thirty participants received Blue Dotted Elmore Oil and another thirty received the Orange dotted Elmore Oil, they applied the oils three times daily on the affected knees for four weeks and stopped usage on the fifth week (flush out period) and on the 6 week, the two group switched to Orange and Blue Elmore Oil respectively. All throughout applications, they filled out their diaries to indicate changes in their mobility, moods, feeling of well being and ability to do their daily work at home or at work every week.
Also known as: Oily solution in a bottle containing olive oil, tea tree oil, vanilla and eucalyptus., Another oily solution in a bottle containing olive oil.
Decrease in joint swelling, pain and stiffness after each treatment period
Time frame: Every day for 28 days
Detect changes in Full Blood Examination parameters, liver function tests, and kidney function tests, including a CRP and ESR.
Time frame: 28 days
This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.